Vancouver, WA, United States of America

Yuexin Li

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovator Spotlight: Yuexin Li**

Introduction

Yuexin Li, an accomplished inventor based in Vancouver, WA, has made significant contributions to the field of pharmaceuticals with a focus on treating infectious diseases. With a total of two patents to her name, she is recognized for her innovative approaches and dedication to addressing critical health challenges.

Latest Patents

Yuexin's latest patents revolve around the development of 3-aryl quinoline compounds. These innovative compounds, compositions, and associated methods are particularly useful for treating infectious diseases such as malaria. Through her work, she has disclosed the synthesis of these compounds, their pharmaceutical compositions, and the methods for their application in combating infections.

Career Highlights

Throughout her career, Yuexin has been associated with esteemed institutions, including the Oregon Health & Science University and the United States Government as represented by the Department of Veterans Affairs. Her work at these organizations underscores her commitment to advancing medical science and developing new therapies for infectious diseases.

Collaborations

Yuexin has collaborated with notable colleagues such as Michael Kevin Riscoe and Rolf W. Winter. These partnerships have fostered an environment of shared knowledge and innovation, allowing her to enhance the impact of her research and patent work.

Conclusion

As an inventor focused on the development of treatments for infectious diseases, Yuexin Li stands out for her contributions and innovations in the pharmaceutical sector. Her work continues to pave the way for new therapeutic solutions, showcasing her dedication to improving health outcomes globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…